Brief: Celltrion: Signs Supply Contract Worth $142 Mln With Celltrion Healthcare To Provide Biosimilar Products
June 30 (Reuters) -
* S.KOREA'S CELLTRION SAYS SIGNS SUPPLY CONTRACT WORTH 171
BILLION
WON ($142.34 million) WITH CELLTRION HEALTHCARE TO PROVIDE
BIOSIMILAR PRODUCTS
Source text for Eikon: https://bit.ly/3icVpYB
Further company coverage: 068270.KS
($1 = 1,201.3200 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on Celltrion Healthcare Co
See all newsBrief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand
Brief: Celltrion Healthcare To Acquire 92.7 Billion Won Worth Of Own Shares
Brief: Celltrion Healthcare Q3 Operating Profit 50.5 Billion Won, Down 30.4% From Year Earlier
Brief: Celltrion Usa- Announces Distribution And Incorporation Of Yuflyma (Adalimumab-Aaty) To Carepartners Specialty Pharmacy Cost Savings Programs
Brief: Celltrion Healthcare's Merger With Celltrion Approved In Shareholder Meeting -Yonhap